Fuller & Thaler Asset Management
NVS icon

Fuller & Thaler Asset Management’s Novartis NVS Stock Holding History

Fuller & Thaler Asset Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-45
Closed -$4K – 716
2015
Q1 		$4K Buy
+45
New +$3.99K ﹤0.01% 626

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Fuller & Thaler Asset Management's NVS Position: Q2 2015 in Review

Fuller & Thaler Asset Management sold out of Novartis (NVS) in Q2 2015, closing a stake of 45 shares — an estimated $4K sold.

Fuller & Thaler Asset Management first reported a position in NVS in Q1 2015 and held it in 1 quarter. The position peaked at $4K in Q1 2015. 943 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

  • Fuller & Thaler Asset Management reported no remaining Novartis position as of Q2 2015 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 45 Novartis shares in Q2 2015, an estimated $4K.
  • Fuller & Thaler Asset Management first reported a position in Novartis in Q1 2015 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's Novartis position peaked at $4K in Q1 2015.
  • 943 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2015, filed 17 Aug 2015.